Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity Subgroup Analysis and Treatment Facility on Clinical Outcomes

摘要

Disparities exist among patients with pancreatic ductal adenocarcinoma (PDAC). Non‐White race is regarded as a negative predictor of expected treatment and overall survival. Data suggest that Academic Research Programs (ARP) provide better outcomes for minorities, but ethnic/minority outcomes are underreported. We hypothesize that outcomes among racially/ethnically diverse PDAC patients may be influenced by treatment facility.